GODAVARI

Godavari Drugs Share PriceGodavari Drugs

₹77.55
-1.63 (-2.06%)
As on 30 March, 2023 | 17:16 BSE: 530317 NSE: GODAVARI

Godavari Drugs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Godavari Drugs

Start SIP

Godavari Drugs Share Price

  • Over 1 Month -0.39%
  • Over 3 Month -18.33%
  • Over 6 Month 15.57%
  • Over 1 Year 20.51%

Godavari Drugs Key Statistics

Godavari Drugs Investment Rating

  • Master Rating:
  • Godavari Drugs has an operating revenue of Rs. 166.54 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 17% is exceptional. The company has a reasonable debt to equity of 40%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 6% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 23% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 66 which is a FAIR score but needs to improve its earnings, a RS Rating of 71 which is FAIR indicating the recent price performance, Buyer Demand at D which indicates heavy supply, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Godavari Drugs Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 39414344
Operating Expenses Qtr Cr 37384042
Operating Profit Qtr Cr 2323
Depreciation Qtr Cr 1000
Interest Qtr Cr 1111
Tax Qtr Cr 0001
Net Profit Qtr Cr 1111

Godavari Drugs Technicals

EMA & SMA

Current Price
₹77.55
-1.63 (-2.06%)
  • Bullish Moving Average
  • ___
  • 3
  • Bearish Moving Average
  • ___
  • 13
  • 20 Day
  • 79.36
  • 50 Day
  • 80.7
  • 100 Day
  • 79.16
  • 200 Day
  • 75.16
  • 20 Day
  • 78.72
  • 50 Day
  • 82.72
  • 100 Day
  • 79.15
  • 200 Day
  • 73.04

Godavari Drugs Resistance and Support

PIVOT
₹79.06
Resistance
First Resistance 80.12
Second Resistance 81.06
Third Resistance 82.12
RSI 44.49
MFI 54.56
MACD Single Line -1.17
MACD -0.93
Support
First Resistance 78.12
Second Resistance 77.06
Third Resistance 76.12

Godavari Drugs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,906 261,390 66.92
Week 5,390 389,129 72.2
1 Month 5,427 379,571 69.94
6 Month 25,635 1,570,160 61.25

Godavari Drugs Result Highlights

Godavari Drugs Synopsis

BSE-Medical-Generic Drugs

Godavari Drugs is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 161.11 Cr. and Equity Capital is Rs. 7.53 Cr. for the Year ended 31/03/2022. Godavari Drugs Ltd. is a Public Limited Listed company incorporated on 02/12/1987 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230TG1987PLC008016 and registration number is 008016.
Market Cap 59
Sales 167
Shares in Float 0.35
No of funds 4
Yield
Book Value 1.98
U/D Vol ratio 0.6
LTDebt / Equity 40
Alpha 0.14
Beta 0.36

Godavari Drugs

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 53.12%56.92%56.92%
Financial Institutions/ Banks 0.5%0.5%0.5%
Individual Investors 39.26%35.9%35.87%
Others 7.12%6.68%6.71%

Godavari Drugs Management

Name Designation
Mr. Ghanshyam Jaju Chairman
Mr. Mukund Kakani Managing Director
Mr. Mohit Jaju Executive Director
Mr. Kirti Kumar Jain CFO & Wholetime Director
Mr. Dilip Keshavlal Patel Non Exe. & Ind. Director
Mr. Syed Anis Hussain Non Exe. & Ind. Director
Mr. Ramesh Babu Telugu Non Exe. & Ind. Director
Mrs. Vimala Madon Non Exe. & Ind. Director

Godavari Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Godavari Drugs FAQs

What is Share Price of Godavari Drugs ?

Godavari Drugs share price is ₹77 As on 30 March, 2023 | 17:02

What is the Market Cap of Godavari Drugs ?

The Market Cap of Godavari Drugs is ₹58.4 Cr As on 30 March, 2023 | 17:02

What is the P/E ratio of Godavari Drugs ?

The P/E ratio of Godavari Drugs is 15.7 As on 30 March, 2023 | 17:02

What is the PB ratio of Godavari Drugs ?

The PB ratio of Godavari Drugs is 2 As on 30 March, 2023 | 17:02

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number